Spinal Muscular Atrophy Treatment Market Size, Share, Trends, Growth, Production, Consumption, Revenue, Company Analysis and Forecast 2021-2030

Published Date : Feb 2021 | No. of Pages : 250 Pages | Category : Healthcare


Chapter 1.  Introduction

1.1.  Research Objective

1.2.  Scope of the Study

1.3.  Definition

Chapter 2.  Research Methodology

2.1.  Research Approach

2.2.  Data Sources

2.3.  Assumptions & Limitations

Chapter 3.  Executive Summary

3.1.  Market Snapshot

Chapter 4.  Market Variables and Scope

4.1.  Introduction

4.2.  Market Classification and Scope

4.3.  Industry Value Chain Analysis

4.3.1.    Raw Material Procurement Analysis

4.3.2.    Sales and Distribution Channel Analysis

4.3.3.    Downstream Buyer Analysis

Chapter 5.  Market Dynamics Analysis and Trends

5.1.  Market Dynamics

5.1.1.    Market Drivers

5.1.2.    Market Restraints

5.1.3.    Market Opportunities

5.2.  Porter’s Five Forces Analysis

5.2.1.    Bargaining power of suppliers

5.2.2.    Bargaining power of buyers

5.2.3.    Threat of substitute

5.2.4.    Threat of new entrants

5.2.5.    Degree of competition

Chapter 6.  Competitive Landscape

6.1.1.    Company Market Share/Positioning Analysis

6.1.2.    Key Strategies Adopted by Players

6.1.3.    Vendor Landscape

6.1.3.1.        List of Suppliers

6.1.3.2.        List of Buyers

Chapter 7.  Global Spinal Muscular Atrophy Treatment Market, Disease Type

7.1.  Spinal Muscular Atrophy Treatment Market, Disease Type, 2021-2028

7.1.1.    Type 1

7.1.1.1.        Market Revenue and Forecast (2016-2028)

7.1.2.    Type 2

7.1.2.1.        Market Revenue and Forecast (2016-2028)

7.1.3.    Type 3

7.1.3.1.        Market Revenue and Forecast (2016-2028)

7.1.4.    Type 4

7.1.4.1.        Market Revenue and Forecast (2016-2028)

Chapter 8.  Global Spinal Muscular Atrophy Treatment Market, Treatment

8.1.  Spinal Muscular Atrophy Treatment Market, Treatment, 2021-2028

8.1.1.    Gene Therapy

8.1.1.1.        Market Revenue and Forecast (2016-2028)

8.1.2.    Drug

8.1.2.1.        Market Revenue and Forecast (2016-2028)

Chapter 9.  Global Spinal Muscular Atrophy Treatment Market, Route of Administration

9.1.  Spinal Muscular Atrophy Treatment Market, Route of Administration, 2021-2028

9.1.1.    Oral

9.1.1.1.        Market Revenue and Forecast (2016-2028)

9.1.2.    Intrathecal

9.1.2.1.        Market Revenue and Forecast (2016-2028)

Chapter 10.      Global Spinal Muscular Atrophy Treatment Market, Regional Estimates and Trend Forecast

10.1.        North America

10.1.1.  Market Revenue and Forecast, Disease Type (2016-2028)

10.1.2.  Market Revenue and Forecast, Treatment (2016-2028)

10.1.3.  Market Revenue and Forecast, Route of Administration (2016-2028)

10.1.4.  U.S.

10.1.4.1.      Market Revenue and Forecast, Disease Type (2016-2028)

10.1.4.2.      Market Revenue and Forecast, Treatment (2016-2028)

10.1.4.3.      Market Revenue and Forecast, Route of Administration (2016-2028)

10.1.5.  Rest of North America

10.1.5.1.      Market Revenue and Forecast, Disease Type (2016-2028)

10.1.5.2.      Market Revenue and Forecast, Treatment (2016-2028)

10.1.5.3.      Market Revenue and Forecast, Route of Administration (2016-2028)

10.2.        Europe

10.2.1.  Market Revenue and Forecast, Disease Type (2016-2028)

10.2.2.  Market Revenue and Forecast, Treatment (2016-2028)

10.2.3.  Market Revenue and Forecast, Route of Administration (2016-2028)

10.2.4.  UK

10.2.4.1.      Market Revenue and Forecast, Disease Type (2016-2028)

10.2.4.2.      Market Revenue and Forecast, Treatment (2016-2028)

10.2.4.3.      Market Revenue and Forecast, Route of Administration (2016-2028)

10.2.5.  Germany

10.2.5.1.      Market Revenue and Forecast, Disease Type (2016-2028)

10.2.5.2.      Market Revenue and Forecast, Treatment (2016-2028)

10.2.5.3.      Market Revenue and Forecast, Route of Administration (2016-2028)

10.2.6.  France

10.2.6.1.      Market Revenue and Forecast, Disease Type (2016-2028)

10.2.6.2.      Market Revenue and Forecast, Treatment (2016-2028)

10.2.6.3.      Market Revenue and Forecast, Route of Administration (2016-2028)

10.2.7.  Rest of Europe

10.2.7.1.      Market Revenue and Forecast, Disease Type (2016-2028)

10.2.7.2.      Market Revenue and Forecast, Treatment (2016-2028)

10.2.7.3.      Market Revenue and Forecast, Route of Administration (2016-2028)

10.3.        APAC

10.3.1.  Market Revenue and Forecast, Disease Type (2016-2028)

10.3.2.  Market Revenue and Forecast, Treatment (2016-2028)

10.3.3.  Market Revenue and Forecast, Route of Administration (2016-2028)

10.3.4.  India

10.3.4.1.      Market Revenue and Forecast, Disease Type (2016-2028)

10.3.4.2.      Market Revenue and Forecast, Treatment (2016-2028)

10.3.4.3.      Market Revenue and Forecast, Route of Administration (2016-2028)

10.3.5.  China

10.3.5.1.      Market Revenue and Forecast, Disease Type (2016-2028)

10.3.5.2.      Market Revenue and Forecast, Treatment (2016-2028)

10.3.5.3.      Market Revenue and Forecast, Route of Administration (2016-2028)

10.3.6.  Japan

10.3.6.1.      Market Revenue and Forecast, Disease Type (2016-2028)

10.3.6.2.      Market Revenue and Forecast, Treatment (2016-2028)

10.3.6.3.      Market Revenue and Forecast, Route of Administration (2016-2028)

10.3.7.  Rest of APAC

10.3.7.1.      Market Revenue and Forecast, Disease Type (2016-2028)

10.3.7.2.      Market Revenue and Forecast, Treatment (2016-2028)

10.3.7.3.      Market Revenue and Forecast, Route of Administration (2016-2028)

10.4.        MEA

10.4.1.  Market Revenue and Forecast, Disease Type (2016-2028)

10.4.2.  Market Revenue and Forecast, Treatment (2016-2028)

10.4.3.  Market Revenue and Forecast, Route of Administration (2016-2028)

10.4.4.  GCC

10.4.4.1.      Market Revenue and Forecast, Disease Type (2016-2028)

10.4.4.2.      Market Revenue and Forecast, Treatment (2016-2028)

10.4.4.3.      Market Revenue and Forecast, Route of Administration (2016-2028)

10.4.5.  North Africa

10.4.5.1.      Market Revenue and Forecast, Disease Type (2016-2028)

10.4.5.2.      Market Revenue and Forecast, Treatment (2016-2028)

10.4.5.3.      Market Revenue and Forecast, Route of Administration (2016-2028)

10.4.6.  South Africa

10.4.6.1.      Market Revenue and Forecast, Disease Type (2016-2028)

10.4.6.2.      Market Revenue and Forecast, Treatment (2016-2028)

10.4.6.3.      Market Revenue and Forecast, Route of Administration (2016-2028)

10.4.7.  Rest of MEA

10.4.7.1.      Market Revenue and Forecast, Disease Type (2016-2028)

10.4.7.2.      Market Revenue and Forecast, Treatment (2016-2028)

10.4.7.3.      Market Revenue and Forecast, Route of Administration (2016-2028)

10.5.        Latin America

10.5.1.  Market Revenue and Forecast, Disease Type (2016-2028)

10.5.2.  Market Revenue and Forecast, Treatment (2016-2028)

10.5.3.  Market Revenue and Forecast, Route of Administration (2016-2028)

10.5.4.  Brazil

10.5.4.1.      Market Revenue and Forecast, Disease Type (2016-2028)

10.5.4.2.      Market Revenue and Forecast, Treatment (2016-2028)

10.5.4.3.      Market Revenue and Forecast, Route of Administration (2016-2028)

10.5.5.  Rest of LATAM

10.5.5.1.      Market Revenue and Forecast, Disease Type (2016-2028)

10.5.5.2.      Market Revenue and Forecast, Treatment (2016-2028)

10.5.5.3.      Market Revenue and Forecast, Route of Administration (2016-2028)

Chapter 11.  Company Profiles

11.1.              Biogen

11.1.1.  Company Overview

11.1.2.  Product Offerings

11.1.3.  Financial Performance

11.1.4.  Recent Initiatives

11.2.              Novartis AG

11.2.1.  Company Overview

11.2.2.  Product Offerings

11.2.3.  Financial Performance

11.2.4.  Recent Initiatives

11.3.              Genentech, Inc.

11.3.1.  Company Overview

11.3.2.  Product Offerings

11.3.3.  Financial Performance

11.3.4.  Recent Initiatives

11.4.              F. Hoffmann-La Roche Ltd

11.4.1.  Company Overview

11.4.2.  Product Offerings

11.4.3.  Financial Performance

11.4.4.  Recent Initiatives

11.5.              Astellas Pharma Inc.

11.5.1.  Company Overview

11.5.2.  Product Offerings

11.5.3.  Financial Performance

11.5.4.  Recent Initiatives

11.6.              Genzyme Corporation.

11.6.1.  Company Overview

11.6.2.  Product Offerings

11.6.3.  Financial Performance

11.6.4.  Recent Initiatives

Chapter 12.  Research Methodology

12.1.              Primary Research

12.2.              Secondary Research

12.3.              Assumptions

Chapter 13.  Appendix

13.1.              About Us

13.2.              Glossary of Terms

Featured Research Reports

  • Featured Research Reports

    Non-Surgical Rhinoplasty Market (By Application: Indentations, Convex or concave nose, Asymmetry; By Type; By End-use) - Global Industry Analysis, Size, Share, Growth, Trends, Revenue, Regional Outlook and Forecast 2022-2030

    Read more...
  • Featured Research Reports

    U.S. Urgent Care Market (By Application: Acute Respiratory Infection, Injuries, Joint/Soft Tissue Issues; By Ownership) - Industry Analysis, Size, Share, Growth, Trends, Revenue, Regional Outlook and Forecast 2022-2030

    Read more...
  • Featured Research Reports

    Glaucoma Surgery Devices Market (By Product: Glaucoma Drainage Device, Laser System; By Surgery Method; By End User) - Global Industry Analysis, Size, Share, Growth, Trends, Revenue, Regional Outlook and Forecast 2022-2030

    Read more...
  • Featured Research Reports

    Transcatheter Aortic Valve Replacement Market (By Procedure: Transapical, Transfemoral, Transaortic)- Global Industry Analysis, Size, Share, Growth, Trends, Revenue, Regional Outlook and Forecast 2022-2030

    Read more...
  • Featured Research Reports

    Bioadhesive Wound Care Market (By Type: Fibrin Based Bioadhesive, PEG Based Bioadhesive, Cyanoacrylate Based Bioadhesive; By Application) - Global Industry Analysis, Size, Share, Growth, Trends, Revenue, Regional Outlook and Forecast 2022-2030

    Read more...